Alkaloids from cyanobacteria with diverse powerful bioactivities

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 10, 2010, Pages 946-955

  Vasas, G ^a   Borbely, G ^a   Nanasi P ^a   Nanas P P ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Anatoxin A; Cyanobacterial alkaloids; Cylindrospermopsin; Indole alkaloids; Saxitoxin

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; 7,8,9 GUANIDINIUM; 9 AZABICYCLO[ 4,2,1 ]NONANE; ALANINE DERIVATIVE; ALKALOID DERIVATIVE; AMINO ACID DERIVATIVE; ANATOXIN; ANATOXIN A; ANATOXIN AS; BETA METHYLAMINO LEVO ALANINE; BETA OXALYLAMINOALANINE; CHOLINESTERASE INHIBITOR; COCAINE; CYLINDROSPERMOPSIN; DEOXYCYLINDROSPERMOPSIN; GLUTAMATE RECEPTOR ANTAGONIST; GUANIDINE DERIVATIVE; HOMOANATOXIN A; HOMOTROPANE; INDOLE ALKALOID; KAINIC ACID; NEOSAXITOXIN; NEUROMUSCULAR BLOCKING AGENT; NICOTINE; ORGANOPHOSPHATE; PROADIFEN; PROTEIN SYNTHESIS INHIBITOR; QUISQUALIC ACID; SAXITOXIN; TROPANE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BRAIN; CRYSTAL STRUCTURE; CYANOBACTERIUM; CYTOTOXICITY; DRUG ACTIVITY; DRUG CONFORMATION; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG INHIBITION; DRUG ISOLATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PHARMACODYNAMICS; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

ALKALOIDS; CHOLINESTERASES; CYANOBACTERIA; INDOLES; PROTEIN BIOSYNTHESIS; RECEPTORS, NICOTINIC; SAXITOXIN; SODIUM CHANNELS; TROPANES; URACIL;

EID: 77956705096     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955710792007231     Document Type: Article

References (108)

1. Seigler, D.S. Plant Secondary Metabolism, Kluwer: Boston, 1998.
2. Pelletier, S.W. Alkaloids: Chemical and Biological Perspectives,Vol. 1, Wiley: New York, 1983.
3. Roberts, M.F.; Wink, M. Alkaloids Biochemistry, EcologicalFunctions and Medical Applications, Plenum Press: New York,1998.
4. Dewick, P.M. Medicinal Natural Products, A Biosynthetic Ap-proach, Wiley: New York, 2002.
5. Wink, M. Evolution of secondary metabolites from an ecologicaland molecular phylogenetic perspective. Phytochemistry, 2003, 64,3-19.
6. Wink, M.; Schimmer, O. In Function of Plant Secondary Metabo-lites and Their Exploitation in Biotechnology; Wink M., Ed.; Aca-demic Press and CRC Press, Annual Plant Reviews: Sheffield,1999; Vol. 3, pp. 17-33.
7. Luckner, M. Secondary Metabolism in Microorganisms, Plants andAnimals, Springer: Heidelberg, 1990.
8. Holzinger, F.; Wink, M. Mediation of cardiac glycoside insensitiv-ity in the Monarch butterfly (Danaus plexippus): Role of an aminoacid substitution in the ouabain binding site of Na+,K+-ATPase. J.Chem. Ecol., 1996, 22, 1921-37.
9. Wink, M. In Bioactive Natural Products, Rahman A. U., Ed.; El-sevier: Amsterdam, 2000; Vol. 11, pp. 3-29.
10. Brown, K.S.; Trigo, J.L. In The Alkaloids; Cordell G., Ed.; Aca-demic Press: San Diego, 1995; Vol. 47, pp. 227-54.
11. Lehtonen, P.; Helander, M.; Wink, M.; Sporer, F.; Saikkonen, K.Transfer of endophyte-origin defensive alkaloids from a grass to ahemiparasitic plant. Ecol. Lett., 2006, 8, 1256-63.
12. Wink, M. In The Alkaloids: Chemistry and Biology, Cordell, G.Ed.; Academic Press: San Diego 1993; Vol. 43, 1-18.
13. Whitton, A.; Potts, M. The Ecology of Cyanobacteria, Kluwer:Dordrecht, 2000.
14. Carmichael, W.W.; Biggs, D.F.; Gorham, P.R. Toxicology andpharmacological action of anabaena flos-aquae toxin. Science,1975, 187, 542-44.
15. Francis, G. Poisonous Australian Lake. Nature, 1878, 18, 11.-12.
16. Carmichael, W.W. The cyanotoxins. Adv. Bot. Res., 1997, 27, 211-56.
17. Carmichael, W.W. Heath Effects of Toxin-Producing cyanobacte-ria: The CyanoHABs. Hum. Ecol. Risk Assess., 2001, 7, 1393-07.
18. Fattorusso, E.; Taglialatela-Scafati, O. Modern Alkaloids. Struc-ture, Isolation, Synthesis and Biology, Wiley-VCH: Wein-heim, 2008.
19. Gorham, P.R.; McLachlan, J.; Hammar, U.T.; Kim, W.K. Isolationand culture of toxic strains of Anabaena flos-aquae (Lyngb.) de.Bréb. Verh. Internat. Verein. Limnol., 1964, 1, 796-04.
20. Devlin, J.P.; Edwards, O.E.; Gorham, P.R.; Hunter, N.R.; Pike, R.K.; Stavric, B. Anatoxin-a, a toxic alkaloid from Anabaena flos-aquae NRC-44-1. Can. J. Chem., 1977, 55, 1367-71.
21. Edwards, C.; Beattie, K.A.; Scrimgeour, C.M.; Codd, G.A. Identi-fication of anatoxin-A in benthic cyanobacteria (blue-green algae)and in associated dog poisonings at Loch Insh, Scotland. Toxicon,1992, 30, 1165-75.
22. Carmichael, W.W., Biggs, D.F.; Peterson, M.A. Pharmacology ofanatoxin-a, produced by the freshwater cyanophyte Anabaena flos-aquae NRC-44-1. Toxicon, 1979, 17, 229-36.
23. Holladay, M.W.; Dart, M.J.; Lynch, J.K. Neuronal nicotinic acetyl-choline receptors as targets for drug discovery J. Med. Chem.,1997, 40, 4169-94.
24. Daly, J.W. Nicotinic agonists, antagonists, and modulators fromnatural sources Cell. Mol. Neurobiol., 2005, 25, 513-52.
25. Campbell, H.F.; Edwards, O.E.; Kolt, R. Synthesis of norana-toxin-a and anatoxin-a. Can. J. Chem., 1977, 55, 1372-79.
26. Swanson, K.L.; Allen, C.N.; Aronstam, R.S.; Rapoport, H.; Albu-querque, E.X. Molecular mechanisms of the potent and stereo-specific nicotinic receptor agonist (+)-anatoxin-a. Mol. Pharmacol.,1986, 29, 250-57.
27. Macallan, D.R.E.; Lunt, G.G.; Wonnacott, S.; Swanson, K.L.; Rapoport, H.; Albuquerque, E.X. Methyllycaconitine and anatoxin-a differentiate between nicotinic receptors in vertebrate and inver-tebrate CNS. FEBS Lett., 1988, 226, 357-63.
28. Wonnacott, S.; Gallagher, T. The Chemistry and Pharmacology ofAnatoxin-a and Related Homotropanes with respect to NicotinicAcetylcholine Receptors Mar. Drugs, 2006, 4, 228-54.
29. Gohlke, H.; Gundisch, D.; Schwarz, S.; Seitz, G.; Tilotta, M.C.; Wegge, T. Synthesis and nicotinic binding studies on enantiopurediazine analogues of the novel (2-chloro-5-pyridyl)-9 azabicy-clo [4.2.1]non-2-ene UB-165. J. Med. Chem., 2002, 45, 1064-72.
30. Skulberg, O.M.; Carmichael, W.W.; Andersen, R.A.; Matsunaga, S.; Moore, R. E.; Skulberg, R. Investigations of a neurotoxic Oscil-latorialean strain (cyanophyceae) and its toxin. Isolation and char-acterization of homoanatoxin-a. Environ. Toxicol. Chem., 1992, 11,321-29.
31. Namikoshi, M.; Murakami, T.; Watanabe, M.F.; Oda, T.; Yamada, J.; Tsujimura, S.; Nagai, H.; Oishi, S. Simultaneous production ofhomoanatoxin-a, anatoxin-a, and a new non-toxic 4-hydroxy-homoanatoxin-a by the cyanobacterium Raphidiopsis mediterraneaSkuja. Toxicon, 2003, 42, 533-38.
32. Furey, A., Crowley, J., Shuilleabhain, A.N., Skulberg, A.M., James, K.J. The first identification of the rare cyanobacterial toxin,homoanatoxin-a, in Ireland. Toxicon, 2003, 41, 297-03.
33. Lilleheil, G.; Andersen, R.A.; Skulberg, O.M.; Alexander, J. Ef-fects of a homoanatoxin-a-containing extract from Oscillatoriaformosa (Cyanophyceae/cyanobacteria) on neuromuscular trans-mission. Toxicon, 1997, 35, 1275-89.
34. Onodera, H.; Oshima, Y.; Henriksen, P.; Yasumoto, T.Confirmation of anatoxin-a(s), in the cyanobacterium Anabaenalemmermannii, as the cause of bird kills in Danish Lakes Toxicon,1997, 35, 1645-48.
35. Neumann, R.; Peter, H.H. Insecticidal organophosphates: naturemade them first. Experientia, 1987, 43, 1235-37.
36. Hyde, E.G.; Carmichael, W.W. Anatoxin-a(s), a naturally occurringorganophosphate, is an irreversible active site-directed inhibitor ofacetylcholinesterase (EC 3.1.1.7). J. Biochem. Toxicol., 1991, 6,195-01.
37. Mahmood, N.A.; Carmichael, W.W. Anatoxin-a(s), an anticho-linesterase from the cyanobacterium Anabaena flos-aquae NRC-525-17. Toxicon, 1987, 25, 1221-27.
38. Pomati, F.; Sacchi, S.; Rossetti, C.; Giovannardi, S.; Onodera, H.; Oshima, Y.; Neilan, B.A. The freshwater cyanobacterium Plank-tothrix sp. FP1: molecular identification and detection of paralythicshellfish poisoning toxins. J. Phycol., 2000, 36, 553-62.
39. Pomati, F.; Moffitt, M.C.; Cavaliere, R.; Neilan, B.A. Evidence fordifferences in the metabolism of saxitoxin and C1+2 toxins in thefreshwater cyanobacterium Cylindrospermopsis raciborskii T3.Biochim. Biophys. Acta, 2004, 1674, 60-67.
40. Pomati, F.; Burns, B.P.; Neilan, B.A. Identification of an Na(+)-dependent transporter associated with saxitoxin-producing strainsof the cyanobacterium Anabaena circinalis. Appl. Environ. Micro-biol., 2004, 70, 4711-19.
41. Llewellyn, L.E. Saxitoxin, a toxic marine natural product that tar-gets a multitude of receptors. Nat. Prod. Rep., 2006, 23, 200-22.
42. Schantz, E.J.; Mcfarren, E.F.; Schafer, M.L.; Lewis, K.H. Purifiedshellfish poison for bioassay standardization. J. Assoc. Off. Agric.Chem., 1958, 41, 160-68.
43. Alam, M., Oshima, Y., Shimizu, Y. About Gonyautoxins-1, -11, -111 and-1V. Tetrahedron Lett., 1982, 23, 321-22.
44. Schantz, E.J. J. Studies of shellfish poisons. Agric. Food. Chem.,1969, 17, 413-16.
45. Schantz, E.J.; Ghazarossian, V.E.; Schnoes, H.K.; Strong, F.M.; Springer, J.P.; Pezzanite, J.O.; Clardy, J. The structure of saxitoxin.J. Am. Chem. Soc., 1975, 97, 1238-39.
46. Kao, C.Y.; Nishiyama, A. Actions of saxitoxin on peripheral neu-romuscular systems. J. Physiol., 1965, 180, 50-66.
47. Kao, P.N.; Jameskracke, M.R.; Kao, C.Y. The active guanidiniumgroup of saxitoxin and neosaxitoxin identified by the effects of pHon their activities on squid axon. Pflugers Arch. Eur. J. Physiol.,1983, 398, 199-03.
48. Catterall, W.A. Neurotoxins that act on voltage-sensitive sodiumchannels in excitable membranes. Annu. Rev. Pharmacol. Toxicol.,1980, 20, 15-43.
49. Kao, C.Y. Tetrodotoxin, saxitoxin and their significance in thestudy of excitation phenomena. Pharmacol. Rev., 1966, 18, 997-49.
50. Henderson, R.; Ritchie, J.M.; Strichartz, G. The binding of labelledsaxitoxin to the sodium channels in nerve membranes. J. Physiol.,1973, 235, 783-04.
51. Ritchie, J.M. Binding of tetrodotoxin and saxitoxin to sodiumchannels. Philos. Trans. R. Soc. Lond. Ser. B, 1975, 270, 319-35.
52. Ritchie, J.M.; Rogart, R.B.; Strichartz, G.R. A new method forlabelling saxitoxin and its binding to non-myelinated fibres of therabbit vagus, lobster walking leg, and garfish olfactory nerves. J.Physiol., 1976, 261, 477-94.
53. Keynes, R.D.; Ritchie, J.M. On the binding of labelled saxitoxin tothe squid giant axon. Proc. R. Soc. Lond. Ser. B, 1984, 222, 147-53.
54. Andrinolo, D.; Michea, L.F.; Lagos, N. Toxic effects, pharmacoki-netics and clearance of saxitoxin, a component of paralytic shellfishpoison (PSP), in cats. Toxicon, 1999, 37, 447-64.
55. Borison, H.L.; Culp, W.J.; Gonsalves, S.F.; Mccarthy, L.E. Centralrespiratory and circulatory depression caused by intravascular saxi-toxin Br. J. Pharmacol., 1980, 68, 301-09.
56. Chang, F.C.T.; Benton, B.J.; Lenz, R.A.; Capacio, B.R. Electro-physiological Analysis of Saxitoxin (Stx) Induced Central Respira-tory Effects. Toxicon, 1993, 31, 645-64.
57. Kao, C.Y.; Suzuki, T.; Kleinhaus, A.L.; Siegman, M.J. Vasomotorand respiratory depressant actions of tetrodotoxin and saxitoxin.Arch. Int. Pharmacodyn. Ther., 1967, 165, 438-50.
58. Wang, J.X.; Salata, J.J.; Bennett, P.B. Saxitoxin is a gating modi-fier of HERG K + channels. J. Gen. Physiol., 2003, 121, 583-98.
59. Adams, H.J.; Blair, M.R.; Takman, B.H. The local anesthetic activ-ity of saxitoxin alone and with vasoconstrictor and local anestheticagents. Arch. Int. Pharmacodyn. Ther., 1976, 224, 275-82.
60. Barnet, C.S., Tse, J.Y., Kohane, D.S. Site 1 sodium channel block-ers prolong the duration of sciatic nerve blockade from tricyclic an-tidepressants. Pain, 2004, 110, 432-38.
61. Kohane, D.S.; Lu, N.T.; Gokgol-Kline, A.C.; Shubina, M., Kuang, Y.; Hall, S.; Strichartz, G.R.; Berde, C.B. The local anestheticproperties and toxicity of saxitonin homologues for rat sciatic nerveblock in vivo. Reg. Anesth. Pain Med., 2000, 25, 52-59.
62. Duncan, M.W.; Kopin, I.J.; Garruto, R.M.; Lavine, L.; Markey,S.P. 2-Amino-3 (methylamino)-propionic acid in cycad-derivedfoods is an unlikely cause of amyotrophic lateral sclero-sis/parkinsonism. Lancet, 1988, 631-32.
63. Weiss, J.H.; Koh, J.Y.; Choi, D.W. The calcium channel blockernifedipine attenuates slow excitatory amino acid neurotoxicity.Brain Res., 1989, 497, 64-71.
64. Brownson, D.M.; Mabry, T.J.; Leslie, S.W. The cycad neurotoxicamino acid, -N-methylamino-alanine (BMAA), elevates intracel-lular calcium levels in dissociated rat brain cells. J. Ethnopharma-col., 2002, 82, 159-67.
65. Vega, A.; Bell, E.A. -amino-methylaminopropionic acid, a newamino acid from seeds of Cycas circinalis. Phytochemistry, 1967,6, 759-62.
66. Schneider, D.; Wink, M.; Sporer, F.; Lounibos, P. Cycads: Theirevolution, toxins, herbivores and insect pollinators. Naturwiss.,2002, 89, 281-94.
67. Cox, P.A.; Banack, S.A.; Murch, S.J. Biomagnification ofcyanobacterial neurotoxins and neurodegenerative disease amongthe Chamorro people of Guam Proc. Natl. Acad. Sci. U.S.A., 2003,100, 13380-03.
68. Nunn, P.B.; Seelig, M.; Zagoren, J.C.; Spencer, P.S. Stereospecificacute neuronotoxicity of 'uncommon' plant amino acids linked tohuman motor-system diseases. Brain Res., 1987, 410, 375-79.
69. Perry, T.L.; Bergeron, C.; Biro, A.J.; Hansen, S. Beta-N-methylamino-L-alanine. Chronic oral administration is not neuro-toxic to mice. J. Neurol. Sci., 1989, 94, 173-80.
70. Spencer, P.S.; Nunn, P.B.; Hugon, J.; Ludolph, A.C.; Ross, S.M.; Roy, D.N.; Robertson, R.C. Guam amyotrophic lateral sclerosislinked to a plant excitant neurotoxin. Science, 1987, 237, 517-22.
71. Copani, A.; Canonico, P.L.; Nicoletti, F. Beta-N-methylamino-L-alanine (L-BMAA) is a potent agonist of 'metabolotropic' gluta-mate receptors. Eur. J. Pharmacol., 1990, 181, 327-28.
72. Allen, C.N.; Omelchenko, I.; Ross, M.; Spencer, P. The neurotoxin,-N-methylamino-L -alanine (BMAA) interacts with thestrychnine-insensitive glycine modulatory site of the N-methyl-D -aspartate receptor. Neuropharmacology, 1995, 34, 651-58.
73. Allen, C.N.; Spencer, P.S.; Carpenter, D.O. ß-N-methylamino-L-alanine (BMAA) in the presence of bicarbonate is an agonist atnon-NMDA type receptors. Neuroscience, 1993, 54, 567-74.
74. Fastner, J.; Heinze, R.; Humpage A.R.; Mischke, U.; Eaglesham, GK.; Chorus, I. Cylindrospermopsin occurrence in two German la-kes and preliminary assessment of toxicity and toxin production ofCylindrospermopsis raciborskii (Cyanobacteria) isolates. Toxicon.2003, 42, 313-21.
75. Humpage, A.; Fenech, M.; Thomas, P.; Falconer, I. Micronucleusinduction and chromosome loss in transformed human white cellsindicate clastogenic and aneugenic action of the cyanobacterialtoxin, cylindrospermopsin. Mutat. Res., 2000, 472, 155-61.
76. Ohtani, I., Moore, R.E.; Runnegar, M.T.C. Cylindrospermopsin: apotent hepatotoxin from the blue-green alga Cylindrospermopsisraciborskii J. Am. Chem. Soc. 1992, 114, 7941-42.
77. Li, R.; Carmichael, W.W.; Brittain, S.; Eaglesham, G.K.; Shaw, G.R.; Liu, Y.; Watanabe, M.M. First report of the cyanotoxinscylindrospermopsin and deoxycylindrospermopsin fromRaphidiopsis Curvata (cyanobacteria). J. Phycol., 2001, 37, 1121-26.
78. Norris, R.L; Eaglesham, G.K.; Pierens, G.; Shaw, G.R.; Smith, M.J.; Chiswell, R.K.; Seawright, A.A.; Moore, M.R. Deoxycylin-drospermopsin, an analog of cylindrospermopsin from Cylindros-permopsis raciborskii. Environ. Toxicol., 1999, 14, 163-65.
79. Banker R.; Carmeli S.; Werman M.; Teltsch B.; Porat R.; SukenikA. Uracil Moiety is Required for Toxicity of the CyanobacterialHepatotoxin Cylindrospermopsin. J. Toxicol. Environ. Health PartA, 2001, 62, 281-88.
80. Chiswell, R.K., G.R. Shaw, G. Eaglesham, M.J. Smith, R.L. Norris, A.A. Seawright, and M.R. Moore. Stability of cylindrospermopsin,the toxin from the cyanobacterium, Cylindrospermopsis racibor-skii: Effect of pH, temperature, and sunlight on decomposition. En-viron. Toxicol. 1999, 14, 155-61.
81. Shen, X.; Lam, P.K.S.; Shaw, G.R.; Wickramasinghe, W. Genotox-icity investigation of a cyanobacterial toxin, cylindrospermopsin.Toxicon, 2002, 40, 1499-01.
82. Humpage, A.R., Fontaine, F.; Froscio, S.; Burcham, P.; Falconer, I.R.J. Cylindrospermopsin genotoxicity and cytotoxicity: role ofcytochrome P-450 and oxidative stress. Toxicol. Environ. HealthA., 2005, 14, 739-53.
83. Shaw, G.R.; Seawright, A.A.; Moore, M.R.; Lam, P.K.S. Cylin-drospermopsin, A cyanobacterial alkaloid: Evaluation of its toxi-cologic activity Ther. Drug Monit. 2000, 22, 89-92.
84. Runnegar, M.T.; Xie, C.; Snider, B.B.; Wallace, G.A.; Weinreb, S.M.; Kuhlenkamp, J. In vivo hepatotoxicity of the cyanobacterialalkaloid cylindrospermopsin and related synthetic analogues. Toxi-col. Sci. 2002, 67, 81-87.
85. Bhat, S. V.; Nagasampagni, B. A.; Sivakumar, M. Chemistry ofNatural Products; Springer Verlag: Berlin, 2005.
86. Larsen, L.K.; Moore, R.E.; Patterson, G.M.L. beta-Carbolines fromthe blue-green alga Dichothrix baueriana. J. Nat. Prod., 1994, 57,419-21.
87. Volk, R.B. Screening of microalgal culture media for the presenceof algicidal compounds and isolation and identification of two bio-active metabolites, excreted by the cyanobacteria Nostoc insulareand Nodularia harveyana. J. Appl. Phycol., 2005, 17, 339-47.
88. Moore, R.E.; Cheuk, C.; Patterson, G.M.L. Hapalindoles: newalkaloids from the blue-green alga Hapalosiphon fontinalis. J. Am.Chem. Soc., 1984, 106, 6456-57.
89. Moore, R.E.; Cheuk, C.; Xu-Qiang, G.Y.; Patterson, G.M.L.; Bon-jouklian, R.; Smitka, T.A.; Mynderse, J.S.; Foster, R.S.; Jones, N.D.; Swartzendruber, J.K.; Deeter, J.B. Hapalindoles, antibacterialand antimycotic alkaloids from the cyanophyte Hapalosiphon fon-tinalis J. Org. Chem., 1987, 52, 1036-43.
90. Smitka, T.A.; Bonjouklian, R.; Doolin, L.; Jones, N.D.; Deeter, J.B.; Yoshida, W.Y.; Prinsep, M.R.; Moore, R.E.; Patterson, G.M.L. Ambiguine Isonitriles, Fungicidal Hapalindole-Type Alka-loids from Three Genera of Blue-Green Algae Belonging to theStogonemataceae. J. Org. Chem., 1992, 57, 857-61.
91. Huber, U.; Moore, R.E.; Patterson, G.M.L. Isolation of a nitrile-containing indole alkaloid from the terrestrial blue-green algaHapalosiphon delicatulus. J. Nat. Prod., 1998, 61, 1304-06.
92. Park, A.; Moore, R.E.; Patterson, G.M.L. Fischerindole, L., a newisonitrile from the terrestrial blue-green alga Fischerella muscicola.Tetrahedron Lett., 1992, 33, 3257-60.
93. Stratmann, K.; Moore, R.E.; Bonjouklian, R.; Deeter, J.B.; Patter-son, G.M.L.; Shaffer, S.; Smith, C.D.; Smitka, T.A. Welwitindoli-nones, unusual alkaloids from the blue-green algae Hapalosiphonwelwitschii and Westiella intricata: relationship to fischerindolesand hapalindoles. J. Am. Chem. Soc., 1994, 116, 9935-42.
94. Bonjouklian, R.; Smitka, T.A.; Doolin, L.E.; Molloy, R.M.; Debono, M.; Shaffer, S.A.; Moore, R.E.; Stewart, J.B.; Patterson, G.M.L. Tjipanazoles, new antifungal agents from the blue-greenalga Tolypothrix tjipanasensis. Tetrahedron, 1991, 47, 7739-50.
95. Furusaki, A.; Hashiba, N.; Matsumoto, T.; Hirano, A.; Iwai, Y.; Omura, S. X-Ray crystal structure of staurosporine: a new alkaloidfrom a Streptomyces strain. Chem. Commun., 1978, 800-01.
96. Tamaoki, T.; Nomoto, H.; Takahashi, I.; Kato, Y.; Morimoto, M.; Tomita, F. Staurosporine, a potent inhibitor of phosphol-ipid/Ca++dependent protein kinase. Biochem. Biophys. Res. Com-mun., 1986, 135, 397-02.
97. Oka, S.; Kodama, M.; Takeda, H.; Tomizuka, N.; Suzuki, H.Staurosporine, a Potent Platelet Aggregation Inhibitor from a Strep-tomyces Species Agric. Biol. Chem., 1986, 50, 2723-27.
98. Nettleton, D.E.; Doyle, T.W.; Krishnan, B.; Matsumoto, G.K.; Clardy, J. Isolation and structure of rebeccamycin a newantitumorantibiotic from Nocardia aerocoligenes. Tetrahedron Lett., 1985,26, 4011-14.
99. Bush, J.A.; Long, B.H.; Catino, J.J.; Bradner, W.T. Production andbiological activity of Rebeccamycin, a novel antitumor agent. J.Antibiotics, 1987, 40, 668-78.
100. Fine, H. A.; Kim, L.; Royce, C.; Draper, D.; Haggarty, I.; Ellin-zano, H.; Albert, P.; Kinney, P.; Musib, L.; Thornton, D. Resultsfrom phase II trial of enzastaurin (LY317615) in patients with re-current high grade gliomas. J. Clin. Oncol., 2005, 23, 115S.
101. Graff, J.R.; McNulty, A.M.; Hanna, K.R.; Konicek, B.W.; Lynch, R.L.; Bailey, S.N.; Banks, C.; Capen, A.; Goode, R.; Lewis, J.E.; Sams, L.; Huss, K.L.; Campbell, R.M.; Iversen, P.W.; Neubauer, B.L.; Brown, T.J.; Musib, L.; Geeganage, S.; Thornton, D. TheProtein Kinase Cß-Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, InducesApoptosis, and Suppresses Growth of Human Colon Cancer andGlioblastoma Xenografts Cancer Res., 2005, 65, 7462-69.
102. Rickards, R.W.; Rothschild, J.M.; Willis, A.C.; de Chazal, N.M.; Kirk, J.; Kirk, K.; Saliba, K.J.; Smith, G.D. Calothrixins A and B,Novel Pentacyclic Metabolites from Calothrix Cyanobacteria withPotent Activity against Malaria Parasites and Human Cancer Cells.Tetrahedron, 1999, 55, 13513-20.
103. Becher, P.G.; Beuchat, J.; Gademann, K.; Jüttner, F. Nostocar-boline: isolation and synthesis of a new cholinesterase inhibitorfrom Nostoc 78-12A J. Nat. Prod., 2005, 68, 1793-95.
104. Blom, J.F.; Brütsch, T.; Barbaras, D.; Bethuel, Y.; Locher, H.H.; Hubschwerlen, C.; Gademann, K. Potent algicides based on the cy-anobacterial alkaloid nostocarboline. Org. Lett., 2006, 8, 737-40.
105. Proteau, P.J.; Gerwick, W.H.; Garciapichel, F.; Castenholz, R. Thestructure of scytonemin, an ultraviolet sunscreen pigment from thesheaths of cyanobacteria. Experientia, 1993, 49, 825-29.
106. Kobayashi, A.; Kajiyama, S.I.; Inawaka, K.; Kanzaki, H.; Kawazu, K. Nostodione A, a novel mitotic spindle poison from a blue-greenalga Nostoc commune. Z. Naturforsch. C, 1994, 49, 464-70.
107. Ploutno, A.; Carmeli, S. Prenostodione, a novel UV-absorbingmetabolite from a natural bloom of the cyanobacterium Nostocspecies. J. Nat. Prod., 2001, 64, 544-45.
108. Gademann, K.; Portmann, C. Secondary Metabolites from Cyano-bacteria: Complex Structures and Powerful Bioactivities. Curr.Org. Chem., 2008, 12, 326-41.